Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum

Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum

Item
http://www.wikidata.org/entity/Q27473432
Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 AssaysComparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5Laboratory Assays for Diagnosis and Management of Hepatitis C Virus InfectionPerformance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA QuantificationVariable ratio of hepatitis C virus RNA to viral core antigen in patient sera.Strengths and limitations of commercial tests for hepatitis C virus RNA quantificationHepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors.Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent.Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections.Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load.Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues.HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.
P2860

Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum

Item
http://www.wikidata.org/entity/Q27473432
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@ast
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@en
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@nl
type
label
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@ast
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@en
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@nl
prefLabel
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@ast
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@en
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Comparative Evaluation of the ...... Hepatitis C Virus RNA in Serum
@en
P2093
P2860
P304
P31
P356
10.1128/JCM.40.2.495-500.2002
P407
P433
P478
P577
P698
P921
P932